Please login to the form below

Not currently logged in
Email:
Password:

Healthcare UK

This page shows the latest Healthcare UK news and features for those working in and with pharma, biotech and healthcare.

Takeda’s HAE drug Takhzyro backed by NICE

Takeda’s HAE drug Takhzyro backed by NICE

a full and active life,” said Laura Szutowicz, chief executive of medical charity HAE UK. ... We hope the NHS and healthcare professionals will provide swift access to patients who could benefit from this new treatment,” she added.

Latest news

More from news
Approximately 3 fully matching, plus 440 partially matching documents found.

Latest Intelligence

  • Building Europe’s next breakthrough biotechs Building Europe’s next breakthrough biotechs

    Start Codon in Cambridge, UK is a new strategic initiative aimed at answering this question by providing guidance and support for a new generation of life science and healthcare companies. ... Taking its name appropriately from a key messenger RNA (mRNA)

  • Women Leaders in UK Healthcare: Liz Henderson Women Leaders in UK Healthcare: Liz Henderson

    Merck UK &Ireland’s MD on her ‘non-linear’ career and the importance of mentoring. ... One of the themes in PME’s Women leaders in UK healthcare is how healthcare stakeholders – especially the pharma industry and the NHS – can better align

  • 25 Women Leaders in UK Healthcare (part 2) 25 Women Leaders in UK Healthcare (part 2)

    25 Women in UK healthcare, Part 2   (Click here for Part 1). ... Read the full interview with Liz, Merck UK &Ireland's managing director  here.

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    Welcome to Pharmaceutical Market Europe’s special feature on 25 Women Leaders in UK Healthcare (Part 1). ... We also wanted to illustrate the diversity of talent working across healthcare and emphasise how seeing UK healthcare as one ecosystem, and

  • The UK’s new medicines pricing deal – opportunities and risks for pharma The UK’s new medicines pricing deal – opportunities and risks for pharma

    Speaking the same language as your customer is always helpful. A single UK deal, an end to flexible pricing. ... By Leela Barham, an independent health economist and policy expert who has worked with stakeholders across the healthcare system, both in the

More from intelligence
Approximately 0 fully matching, plus 50 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 79 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 126 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics